Year: 2021
Type: article
Study design: Observational Study
Abstract: As germline variants can influence cancer patient treatment decisions, outcomes, and counseling, and as the level of genetic predisposition for sporadic childhood acute myeloid leukemia (AML) is not clearly established, we undertook a comprehensive analysis of rare germline variants in childhood AML.As childhood AML is rare, 1 to date, pan-cancer childhood cohorts have included
Source: Blood
Authors: Saumya E. Samaraweera, Paul P. S. Wang, Ka Leung Li, Debora A. Casolari, Jinghua Feng, Mark Pinese, Kyaw Ze Ya Maung, Paul Leo, Mark Cowley, Kelly Perkins, Amanda M. Smith, Jonathan Ellis, Amilia Wee, Devendra K. Hiwase, Hamish S. Scott, Andreas W. Schreiber, Anna L. Brown, Andrew J. Deans, David M. Ross, Andrew S. Moore, Thomas J. Gonda, Christopher N. Hahn, Richard J. D’Andrea
Institutions: South Australia Pathology, University of South Australia, Centre for Cancer Biology, UNSW Sydney, Queensland University of Technology, The University of Queensland, John Radcliffe Hospital, University of Oxford, MRC Weatherall Institute of Molecular Medicine, Royal Adelaide Hospital, The University of Adelaide, St Vincents Institute of Medical Research, Children's Health Queensland Hospital and Health Service
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: National Cancer Institute
OpenAlex ID: W3199553995